Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded 'Gastric cancer' as a related topic and a new resources link to the Genetic and Rare Diseases Information Center on the study page.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check23 days agoChange DetectedDifference0.4%

- Check30 days agoChange DetectedGlossary display was added. The page metadata was updated with new QC-related timestamps and No FEAR Act data text, replacing older entries.SummaryDifference0.4%

- Check44 days agoChange DetectedThe page now displays a revision update: Revision: v3.3.4 replaces Revision: v3.3.3. This appears to be a site maintenance/versioning change with no impact on the study details, eligibility criteria, or results presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded a Locations section with Missouri as a study site; removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.